Identification of a CircRNA-miRNA-mRNA Regulatory Network for Exploring Novel Therapeutic Options for Glioma

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2021 Aug 26

PMID 34434651

Citations 3

Authors

Yi He

Yihong Chen

Yuxin Tong

Wenyong Long

Qing Liu

Affiliations

Soon will be listed here.

Abstract

Background: Glioma is the most common brain neoplasm with a poor prognosis. Circular RNA (circRNA) and their associated competing endogenous RNA (ceRNA) network play critical roles in the pathogenesis of glioma. However, the alteration of the circRNA-miRNA-mRNA regulatory network and its correlation with glioma therapy haven't been systematically analyzed.

Methods: With GEO, GEPIA2, circBank, CSCD, CircInteractome, mirWalk 2.0, and mirDIP 4.1, we constructed a circRNA-miRNA-mRNA network in glioma. LASSO regression and multivariate Cox regression analysis established a hub mRNA signature to assess the prognosis. GSVA was used to estimate the immune infiltration level. Potential anti-glioma drugs were forecasted using the cMap database and evaluated with GSEA using GEO data.

Results: A ceRNA network of seven circRNAs (hsa_circ_0030788/0034182/0000227/ 0018086/0000229/0036592/0002765), 15 miRNAs(hsa-miR-1200/1205/1248/ 1303/3925-5p/5693/581/586/599/607/640/647/6867-5p/767-3p/935), and 46 mRNAs (including 11 hub genes of ARHGAP11A, DRP2, HNRNPA3, IGFBP5, IP6K2, KLF10, KPNA4, NRP2, PAIP1, RCN1, and SEMA5A) was constructed. Functional enrichment showed they influenced majority of the hallmarks of tumors. Eleven hub genes were proven to be decent prognostic signatures for glioma in both TCGA and CGGA datasets. Forty-six LASSO regression significant genes were closely related to immune infiltration. Finally, five compounds (fulvestrant, tanespimycin, mifepristone, tretinoin, and harman) were predicted as potential treatments for glioma. Among them, mifepristone and tretinoin were proven to inhibit the cell cycle and DNA repair in glioma.

Conclusion: This study highlights the potential pathogenesis of the circRNA-miRNA-mRNA regulatory network and identifies novel therapeutic options for glioma.

Citing Articles

Construction of the underlying circRNA-miRNA-mRNA regulatory network and a new diagnostic model in ulcerative colitis by bioinformatics analysis.

Yuan Y, Wu H, Chen Q, Fan H, Shuai B World J Clin Cases. 2024; 12(9):1606-1621.

PMID: 38576737 PMC: 10989427. DOI: 10.12998/wjcc.v12.i9.1606.

Identification of Pseudo-R genes in Vitis vinifera and characterization of their role as immunomodulators in host-pathogen interactions.

Garewal N, Pathania S, Bhatia G, Singh K J Adv Res. 2022; 42:17-28.

PMID: 35933092 PMC: 9788958. DOI: 10.1016/j.jare.2022.07.014.

Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation.

Wen J, Qin L, Chen G, Huang H, Shen M, Pang J Dis Markers. 2022; 2022:7962220.

PMID: 35251377 PMC: 8896954. DOI: 10.1155/2022/7962220.

References

Yang M, Cui G, Ding M, Yang W, Liu Y, Dai D . miR-935 promotes gastric cancer cell proliferation by targeting SOX7. Biomed Pharmacother. 2016; 79:153-8. DOI: 10.1016/j.biopha.2016.01.011. View

Chen W, Cen S, Zhou X, Yang T, Wu K, Zou L . Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis. Front Cell Dev Biol. 2021; 8:624764. PMC: 7820754. DOI: 10.3389/fcell.2020.624764. View

Cao W, Wei W, Zhan Z, Xie D, Xie Y, Xiao Q . Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis. Int J Mol Med. 2018; 41(4):1958-1966. PMC: 5810220. DOI: 10.3892/ijmm.2018.3381. View

Wang D, Tang X, Liang Q, Zeng X, Yang J, Xu J . microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway. J Cell Physiol. 2019; 235(3):2492-2505. DOI: 10.1002/jcp.29154. View

Vlachos I, Zagganas K, Paraskevopoulou M, Georgakilas G, Karagkouni D, Vergoulis T . DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015; 43(W1):W460-6. PMC: 4489228. DOI: 10.1093/nar/gkv403. View

Chen Y, Du M, Yusuying S, Liu W, Tan Y, Xie P . Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27. Exp Cell Res. 2020; 392(2):112038. DOI: 10.1016/j.yexcr.2020.112038. View

Dudekula D, Panda A, Grammatikakis I, De S, Abdelmohsen K, Gorospe M . CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2015; 13(1):34-42. PMC: 4829301. DOI: 10.1080/15476286.2015.1128065. View

Lee K, Chen C, Lee Y, Kao T, Chen K, Fang C . Znf179 induces differentiation and growth arrest of human primary glioblastoma multiforme in a p53-dependent cell cycle pathway. Sci Rep. 2017; 7(1):4787. PMC: 5500472. DOI: 10.1038/s41598-017-05305-0. View

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

10.

Wang C, Xu J, Niu W, Li S . microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway. Br J Biomed Sci. 2018; 76(1):17-23. DOI: 10.1080/09674845.2018.1520066. View

11.

Zhu Z, Shen S, Zhao S, Wang Z . Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis. Onco Targets Ther. 2020; 13:11301-11313. PMC: 7649248. DOI: 10.2147/OTT.S267471. View

12.

Li C, Tian Y, Liang Y, Li Q . Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis. Cancer Cell Int. 2020; 20(1):84. PMC: 7076943. DOI: 10.1186/s12935-020-01168-0. View

13.

Sauvageot C, Weatherbee J, Kesari S, Winters S, Barnes J, DellaGatta J . Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells. Neuro Oncol. 2008; 11(2):109-21. PMC: 2718982. DOI: 10.1215/15228517-2008-060. View

14.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

15.

Khan H, Patel S, Kamal M . Pharmacological and Toxicological Profile of Harmane-β-Carboline Alkaloid: Friend or Foe. Curr Drug Metab. 2017; 18(9):853-857. DOI: 10.2174/1389200218666170607100947. View

16.

Ma Q, Long W, Xing C, Chu J, Luo M, Wang H . Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma. Front Immunol. 2019; 9:2924. PMC: 6308128. DOI: 10.3389/fimmu.2018.02924. View

17.

von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X . Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020; 11(1):1508. PMC: 7083893. DOI: 10.1038/s41467-020-15129-8. View

18.

Lamb J . The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer. 2006; 7(1):54-60. DOI: 10.1038/nrc2044. View

19.

Wang C, Tang D, Wang H, Hu G, Hu S, Li L . Circular RNA hsa_circ_0030018 acts as a sponge of miR-599 to aggravate esophageal carcinoma progression by regulating ENAH expression. J Cell Biochem. 2019; 121(8-9):3730-3738. DOI: 10.1002/jcb.29507. View

20.

Dweep H, Gretz N . miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015; 12(8):697. DOI: 10.1038/nmeth.3485. View